AdaptHealth Corp. Quarterly Operating Income (Loss) in USD from Q1 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
AdaptHealth Corp. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2018 to Q3 2024.
  • AdaptHealth Corp. Operating Income (Loss) for the quarter ending September 30, 2024 was $63.5M.
  • AdaptHealth Corp. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$51.7M, a 85.4% increase year-over-year.
  • AdaptHealth Corp. annual Operating Income (Loss) for 2023 was -$598M, a 414% decline from 2022.
  • AdaptHealth Corp. annual Operating Income (Loss) for 2022 was $190M, a 15.6% decline from 2021.
  • AdaptHealth Corp. annual Operating Income (Loss) for 2021 was $226M, a 216% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$51.7M $63.5M +$525M Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-05
Q2 2024 -$576M $52M -$2.22M -4.08% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 -$574M $50.5M +$24.4M +93% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$598M -$218M -$245M -915% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 -$354M -$461M -$514M -971% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-05
Q2 2023 $160M $54.3M -$4.92M -8.31% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $165M $26.2M -$25.4M -49.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $190M $26.7M -$42.3M -61.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 $233M $52.9M -$22.8M -30.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $256M $59.2M -$6.23M -9.52% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $262M $51.6M +$36.1M +235% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $226M $69.1M +$34.8M +101% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q3 2021 $191M $75.7M +$62.5M +471% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $128M $65.4M +$49.8M +320% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $78.5M $15.4M +$7.19M +87.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $71.3M $34.3M +$33.9M +8584% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 $37.4M $13.3M +$4.54M +52% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $32.9M $15.6M +$659K +4.42% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $32.2M $8.22M +$2.87M +53.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $29.4M $395K -$31.4M -98.8% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 $60.8M $8.72M +$9.17M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $51.7M $14.9M +$15.1M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 $36.5M $5.35M +$5.42M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 $31.1M $31.8M Oct 1, 2018 Dec 31, 2018 10-K 2020-03-06
Q3 2018 -$445K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 -$234K Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-31
Q1 2018 -$72.5K* Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.